Evaluation of biosynthesized silver nanoparticles effects on expression levels of virulence and biofilm‐related genes of multidrug‐resistant Klebsiella pneumoniae isolates

The emergence of multidrug-resistant (MDR) strains of Klebsiella pneumoniae is associated with high morbidity and mortality due to limited treatment options. This study attempts to biologically synthesize silver nanoparticles (AgNPs) and investigate their effect on expression levels of virulence and biofilm-related genes in clinically isolated K. pneumoniae. In this study, biofilm formation ability, antibiotic resistance pattern, extended-spectrum β-lactamases (ESBLs), and carbapenemases production were investigated for 200 clinical isolates of K. pneumoniae using phenotypic methods. Polymerase chain reaction (PCR) was used to detect virulence and biofilm-related genes, ESBL-encoding genes, and carbapenem resistance genes. AgNPs were synthesized using the bio-reduction method. The antibacterial effects of AgNPs were investigated by microdilution broth. In addition, the cytotoxic effect of AgNPs on L929 fibroblast cell lines was determined. The effects of AgNPs on K. pneumoniae virulence and biofilm-related genes (fimH, rmpA, and mrkA) were determined using quantitative real-time PCR. Thirty percent of the isolates produced a strong biofilm. The highest and lowest levels of resistance were observed against amoxicillin/clavulanic acid (95.4%) and tigecycline (96%), respectively. About 31% of isolates were considered positive for carbapenemases, and 75% of the isolates produced an ESBLs enzyme. Different frequencies of mentioned genes were observed. The synthesized AgNPs had a spherical morphology and varied in size. AgNPs inhibited the growth of MDR K. pneumoniae at 128 µg/ml. In addition, AgNPs downregulated the expression of fimH, rmpA, and mrkA genes by 10, 7, and 14-fold, respectively (p < 0.05), also exerted no cytotoxic effect on L929 fibroblast cell lines. It was revealed that AgNPs lead to a decrease in expression levels of virulence and biofilm-related genes; therefore, it was concluded that AgNPs had an excellent antibacterial effect on MDR K. pneumoniae.

[1]  A. Shivaee,et al.  Zinc oxide nanoparticles impact the expression of the genes involved in toxin–antitoxin systems in multidrug‐resistant Acinetobacter baumannii , 2022, Journal of basic microbiology.

[2]  F. Badmasti,et al.  Detection of ESBL and AmpC producing Klebsiella pneumoniae ST11 and ST147 from urinary tract infections in Iran. , 2022, Acta microbiologica et immunologica Hungarica.

[3]  A. Mojtahedi,et al.  The effect of bacterial composition shifts in the oral microbiota on Alzheimer's disease. , 2022, Current molecular medicine.

[4]  Houri Alizadeh,et al.  Resistance profiling of metallo-betalactamase genes in clinical isolates of Enterobacteriaceae: Emergence of multidrug resistance , 2021 .

[5]  L. Moradi,et al.  Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria , 2021, Current Microbiology.

[6]  R. Ranjbar,et al.  Antibiotic resistance, virulence-associated genes analysis and molecular typing of Klebsiella pneumoniae strains recovered from clinical samples , 2021, AMB Express.

[7]  Ahmed Suhail,et al.  Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii , 2021, Scientific Reports.

[8]  Atieh Darbandi,et al.  Analysis of mgrB gene mutations in colistin-resistant Klebsiella pneumoniae in Tehran, Iran , 2020 .

[9]  A. Shariati,et al.  The complex genetic region conferring transferable antibiotic resistance in multidrug-resistant and extremely drug-resistant Klebsiella pneumoniae clinical isolates , 2020, New microbes and new infections.

[10]  M. Khurshid,et al.  Effect of Silver Nanoparticles on Biofilm Formation and EPS Production of Multidrug-Resistant Klebsiella pneumoniae , 2020, BioMed research international.

[11]  I. Akbarzadeh,et al.  Efflux pump inhibitory activity of biologically synthesized silver nanoparticles against multidrug‐resistant Acinetobacter baumannii clinical isolates , 2020, Journal of basic microbiology.

[12]  D. Qu,et al.  Characteristics of Hypervirulent Klebsiella pneumoniae: Does Low Expression of rmpA Contribute to the Absence of Hypervirulence? , 2020, Frontiers in Microbiology.

[13]  V. Vasić,et al.  Green synthesis and characterization of nontoxic L-methionine capped silver and gold nanoparticles. , 2019, Journal of inorganic biochemistry.

[14]  R. Ranjbar,et al.  Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran , 2019, Antimicrobial Resistance & Infection Control.

[15]  B. Buszewski,et al.  Effect of solvent and extraction technique on composition and biological activity of Lepidium sativum extracts. , 2019, Food chemistry.

[16]  Amjad Ali,et al.  Immunoinformatics-Aided Design and Evaluation of a Potential Multi-Epitope Vaccine against Klebsiella Pneumoniae , 2019, Vaccines.

[17]  A. Cross,et al.  Progress towards the development of Klebsiella vaccines , 2019, Expert review of vaccines.

[18]  J. Ahmad,et al.  Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance. , 2019, Journal of infection in developing countries.

[19]  Rokhsareh Mohammadzadeh,et al.  Association between ESBLs Genes and Quinolone Resistance in Uropathogenic Escherichia coli Isolated from Patients with Urinary Tract Infection , 2019 .

[20]  M. Moradi,et al.  Endemic dissemination of different sequence types of carbapenem-resistant Klebsiella pneumoniae strains harboring blaNDM and 16S rRNA methylase genes in Kerman hospitals, Iran, from 2015 to 2017 , 2018, Infection and drug resistance.

[21]  Hasani,et al.  Prevalence of flmA, flmH, mrkA, ecpA, and mrkD virulence genes affecting biofilm formation in clinical isolates of K. pneumonia , 2019 .

[22]  Alireza Salimi Chirani,et al.  The diversity of class B and class D carbapenemases in clinical Acinetobacter baumannii isolates. , 2018, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[23]  F. Jazi,et al.  Evaluation of the Effects of Curcumin Nanoparticles on the Expression of Genes Involved in Biofilm Formation in UPEC , 2018 .

[24]  A. Talebi,et al.  Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. , 2018, Journal of global antimicrobial resistance.

[25]  A. R. Fernandes,et al.  Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans” , 2018, Front. Microbiol..

[26]  Jeet K. Vora,et al.  Antibacterial Activities of Bacteriagenic Silver Nanoparticles Against Nosocomial Acinetobacter baumannii. , 2018, Journal of nanoscience and nanotechnology.

[27]  S. Hamada,et al.  Detection of plasmid-mediated colistin-resistant and carbapenem-resistant genes by multiplex PCR , 2018, MethodsX.

[28]  M. Jamal,et al.  Bacterial biofilm and associated infections. , 2018, Journal of the Chinese Medical Association : JCMA.

[29]  Sabyasachi Das,et al.  Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage , 2017 .

[30]  C. Khursigara,et al.  Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms , 2017, Antimicrobial Agents and Chemotherapy.

[31]  M. El-Gamal,et al.  Recent updates of carbapenem antibiotics. , 2017, European journal of medicinal chemistry.

[32]  D. Shokri,et al.  Resistotyping, phenotyping and genotyping of New Delhi metallo‐&bgr;‐lactamase (NDM) among Gram‐negative bacilli from Iranian patients , 2017, Journal of medical microbiology.

[33]  S. Mohebi,et al.  The evaluation of connection between integrons class I and II and ESBL-producing and Non-ESBL klebsiella pneumoniae isolated from clinical samples, Kerman , 2016 .

[34]  S. Iravani,et al.  Synthesis of silver nanoparticles: chemical, physical and biological methods , 2014, Research in pharmaceutical sciences.

[35]  J. Xicohtencatl-Cortes,et al.  Pathogenic determinants of clinical Klebsiella pneumoniae strains associated with their persistence in the hospital environment , 2014 .

[36]  M. Hanner,et al.  Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae , 2013, Human vaccines & immunotherapeutics.

[37]  S. Prabhu,et al.  Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects , 2012, International Nano Letters.

[38]  Medhat A. Haroun,et al.  Development of immunization trials against Klebsiella pneumoniae. , 2012, Vaccine.

[39]  J. Bellare,et al.  Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents , 2012, International journal of nanomedicine.

[40]  J. Turton,et al.  PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. , 2010, Journal of medical microbiology.

[41]  F. Shahcheraghi,et al.  Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[42]  Ali Fakhimi,et al.  Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[43]  D. Archer,et al.  Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. , 1995, American journal of obstetrics and gynecology.